What's our pharmacologic readiness against a bioterrorism attack?
Bucci
Kathryn K
KK
Pfizer, Inc, New York, NY, USA.
Briscoe-Dwyer
Leigh
L
D023482:Bioterrorism; D002487:Centers for Disease Control and Prevention, U.S.; D004189:Disaster Planning; D004345:Drug Industry; D006801:Humans; D004364:Pharmaceutical Preparations / Q000600:supply & distribution*; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations